Charting the path from pioneering
biology to impactful therapeutics.

We are a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with unmet medical needs in hematology and oncology.

Learn More


Visit Booth 1066 at the American Society of Hematology (ASH) Annual Meeting

The 61st ASH Annual Meeting in Orlando, Florida, will highlight the most innovative topics in malignant and non-malignant hematology. Visit Sierra Oncology’s booth, #1066, to speak with our team!

MOMENTUM Clinical Trial for Patients with Myelofibrosis

The MOMENTUM Clinical Trial is a randomized, double-blind, Phase 3 trial to evaluate the activity of momelotinib versus danazol in symptomatic, anemic subjects with myelofibrosis (MF). The target enrollment for this clinical trial is 180 patients globally.